Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Impulse Control Disorder: full-pipeline trial registry
3 of 4 indexed Impulse Control Disorder trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Impulse Control Disorder: 4 US clinical trials tracked, 3 recruiting.
Impulse Control Disorder is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is West Virginia University, running 1 of these trials.
Enrollment posture brief
Registry condition impulse-control-disorder
OPEN 3 | RECR 75% | LATE 1 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Impulse Control Disorder lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Impulse Control Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Impulse Control Disorder is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Neurostimulation Versus Therapy for Problems With Emotions
Duke University
NCT05712057
Feasibility of Accelerated, Personalized rTMS as an Adjuvant for Impulse Control Disorders: a Pilot Study
M.D. Anderson Cancer Center
NCT06639594
rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease
West Virginia University
NCT06237868
Naltrexone for Impulse Control Disorders in Parkinson's Disease
University of Pennsylvania
NCT01052831
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Impulse Control Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Impulse Control Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Impulse Control Disorder page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Impulse Control Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- West Virginia University sponsors the most Impulse Control Disorder trials on record, review their full trial history before evaluating a specific study. See West Virginia University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Impulse Control Disorder condition card totals 4 registered trials; most-linked intervention Repetitive Transcranial Magnetic Stimulation (rTMS); top US site state West Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.